InsiderDirector

Clay B Siegall Insider Trading Activity

Every SEC Form 4 transaction reported by Clay B Siegall, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Clay B Siegall buying or selling?

Clay B Siegall reported 10 open-market buys ($7.5M) and 61 sells ($170.6M) across 71 Form 4 filings at 4 companies — a net selling position of $163.1M.

Source: SEC EDGAR Form 4

What stands out

  • Clay B Siegall has reported Form 4 transactions at 4 companies; the most active, SEATTLE GENETICS INC /WA (SGEN), accounts for 60 of 71 filings (85%).
  • The most recent Form 4 was accepted on Jun 11, 2026 (4 months ago).
  • In the last 12 months: 5 open-market purchases ($2.0M) and no sales.
  • The largest open-market purchase in the last 12 months was $1000.0K of Immunome Inc. (IMNM) on Dec 18, 2025. SEC ↗

Key Statistics (as of Jun 11, 2026)

Total Form 4 filings
71
SEC EDGAR
Companies
4
Buys (10)
$7.5M
Sells (61)
$170.6M

Insider sentiment

Net selling

Net insider flow of $163.1M in net selling, filed between Jan 17, 2018 – Jun 11, 2026.

Companies Clay B Siegall files for

#CompanyForm 4 filings
1SGENSEATTLE GENETICS INC /WA60
2IMNMImmunome Inc.9
3RAREUltragenyx Pharmaceutical Inc.1
4STTKShattuck Labs, Inc.1

Recent Clay B Siegall transactions

DateTickerRoleTypeSharesValueFiling
Jun 11, 2026STTKDirectorPurchase62.5K$250.0KSEC ↗
Mar 31, 2026IMNMPresident and CEOPurchase25.4K$500.6KSEC ↗
Dec 30, 2025IMNMPresident and CEOPurchase4.7K$100.0KSEC ↗
Dec 22, 2025IMNMPresident and CEOPurchase7.3K$149.1KSEC ↗
Dec 18, 2025IMNMPresident and CEOPurchase46.5K$1000.0KSEC ↗
Mar 26, 2025IMNMPresident and CEOPurchase137.1K$999.5KSEC ↗
Feb 4, 2025IMNMPresident and CEOPurchase150.0K$1.2MSEC ↗
Nov 25, 2024IMNMPresident and CEOPurchase100.0K$962.2KSEC ↗
May 21, 2024IMNMPresident and CEOPurchase100.0K$1.4MSEC ↗
Oct 4, 2023IMNMPresident and CEOPurchase169.2K$1000.0KSEC ↗
May 13, 2022SGENPresident & CEOSale17.0K$2.1MSEC ↗
Apr 23, 2022SGENPresident & CEOSale1.9K$272.0KSEC ↗
Apr 9, 2022SGENPresident and CEOSale17.0K$2.6MSEC ↗
Mar 10, 2022SGENPresident & CEOSale17.0K$2.3MSEC ↗
Feb 10, 2022SGENPresident & CEOSale17.0K$2.4MSEC ↗
Jan 12, 2022SGENPresident & CEOSale17.0K$2.5MSEC ↗
Dec 22, 2021SGENPresident & CEOSale1.2K$183.9KSEC ↗
Dec 9, 2021SGENPresident & CEOSale45.4K$6.8MSEC ↗
Sep 2, 2021SGENPresident & CEOSale14.4K$2.4MSEC ↗
Sep 1, 2021SGENPresident and CEOSale60.4K$10.1MSEC ↗
Aug 19, 2021SGENPresident & CEOSale2.8K$431.1KSEC ↗
Aug 7, 2021SGENPresident & CEOSale29.4K$4.8MSEC ↗
Jul 7, 2021SGENPresident and CEOSale29.4K$4.6MSEC ↗
Jun 5, 2021SGENPresident and CEOSale29.4K$4.2MSEC ↗
May 7, 2021SGENPresident and CEOSale29.4K$4.0MSEC ↗

Showing the 25 most recent filings of 71. Screen every filing.

Clay B Siegall insider trading FAQ

Is Clay B Siegall buying or selling?

Across 71 SEC Form 4 filings, Clay B Siegall reported 10 open-market purchases totaling $7.5M and 61 sales totaling $170.6M — a net selling position of $163.1M.

Which companies does Clay B Siegall file Form 4s for?

Clay B Siegall has reported insider transactions at 4 companies, most often SEATTLE GENETICS INC /WA (SGEN), Immunome Inc. (IMNM), Ultragenyx Pharmaceutical Inc. (RARE), Shattuck Labs, Inc. (STTK).

How far back does Clay B Siegall's filing history go?

Trabud holds Clay B Siegall's SEC Form 4 filings from Jan 17, 2018 – Jun 11, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Clay B Siegall's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Clay B Siegall and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener